Page last updated: 2024-08-05 11:23:16
endocannabinoid
A class of cannabinoids present in mammalian biological fluids and tissues that activate cannabinoid receptors.
ChEBI ID: 67197
Members (6)
Member | Definition | Role |
---|---|---|
anandamide | An N-acylethanolamine 20:4 resulting from the formal condensation of carboxy group of arachidonic acid with the amino group of ethanolamine. | anandamide |
glyceryl 2-arachidonate | An endocannabinoid and an endogenous agonist of the cannabinoid receptors (CB1 and CB2). It is an ester formed from omega-6-arachidonic acid and glycerol. | 2-arachidonoylglycerol |
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine | An N-acylethanolamine 22:6 that is the ethanolamide of (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoic acid. | N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine |
n-oleoylethanolamine | An N-(long-chain-acyl)ethanolamine that is the ethanolamide of oleic acid. The monounsaturated analogue of the endocannabinoid anandamide. | oleoyl ethanolamide |
noladin ether | A monoalkylglycerol that is glycerol which is substituted by a (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraen-1-yl group at position 2. | 2-arachidonyl glyceryl ether |
palmidrol | An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid. | palmitoyl ethanolamide |
Research
Studies (3,897)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 9 (0.23) | 18.7374 |
1990's | 353 (9.06) | 18.2507 |
2000's | 1,463 (37.54) | 29.6817 |
2010's | 1,657 (42.52) | 24.3611 |
2020's | 415 (10.65) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 120 (2.44%) | 5.53% |
Reviews | 555 (11.29%) | 6.00% |
Case Studies | 15 (0.31%) | 4.05% |
Observational | 16 (0.33%) | 0.25% |
Other | 4,208 (85.63%) | 84.16% |